455 Defendants Including 90 Doctors Were Charged in the Largest Healthcare Fraud Takedown of 2026

• Researchers report that a modified form of vitamin B12 may provide a promising new strategy for treating deadly brain cancer. • A two-year clinical trial published in eBioMedicine involving 365 adults aged 55 to 80 found that high-dose omega-3 fish oil supplements did not improve memory or cognitive abilities.

• A recent New England Journal of Medicine (NEJM) pragmatic trial tested a 6-month rifampicin-resistant tuberculosis (RR-TB) regimen, establishing a new benchmark for adaptive evidence generation. • The trial embedded randomization directly into existing treatment infrastructure to bypass the lengthy 18-month site qualification and rigid eligibility criteria typical of conventional Phase 3 development.

• The FDA approved the updated COVID-19 vaccine strain in May, but official guidance on who should receive it remains unavailable. • A critical lack of a quorum since March has stalled the committee responsible for determining eligibility and insurance coverage for the fall rollout.

• Virginia has expanded a measles outbreak from Buckingham County to include Cumberland County as of June 25. • Statewide confirmed cases have now reached 129 in 2026, prompting the Virginia Department of Health (VDH) to issue guidance for residents and visitors.

• Frontline medics warn that the current Ebola outbreak in the Democratic Republic of the Congo could take another six months to bring under control. • The WHO's Africa response lead has critically rated containment efforts as a 3-4 out of 10, highlighting significant lags in the response.

• Emerging public health risks, including the spread of screwworm and flesh-eating bacteria, are increasing following deep budget cuts to federal health agencies under the Trump administration. • These funding reductions have targeted specific health programs, potentially limiting the ability of agencies to track and contain dangerous pathogens.

• A study published in Sage Journals used advanced imaging on 40 Long COVID patients to identify metabolic brain dysfunction in those experiencing post-exertional malaise (PEM). • Research highlights a severe economic impact, revealing that 46% of Long COVID patients are unable to work and are twice as likely to leave the workforce as those who never had the disease.

• A new review published in The Lancet on Tuesday confirms that mRNA vaccines from Pfizer-BioNTech and Moderna are safe and effective. • Led by Manish Sadarangani of B.C. Children's Hospital, researchers analyzed laboratory data, clinical trials, and real-world surveillance from January 2020 through December 2025.

• AbbVie announced positive topline results from the Phase 3 EPCORE DLBCL-4 trial testing the combination of epcoritamab and lenalidomide. • The study focused on adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who had failed two or more previous treatments.

• The current Ebola outbreak in Bundibugyo shows a death rate of 26%, which is significantly lower than the 40-70% fatality rate recorded during the 2014–16 West Africa epidemic. • In other health news, the FDA approved Capvaxive on June 18, 2026, for children aged 2-17 with chronic conditions such as heart disease and diabetes.

• HCA Healthcare has announced a new study published in the New England Journal of Medicine (NEJM) highlighting advancements in CRISPR-based therapies for children. • The research builds upon pioneering work at TriStar Centennial Medical Center and the Sarah Cannon Transplant and Cellular Therapy Network, which performs over 1,600 cellular therapies and transplants annually.